Literature DB >> 7717728

Respiratory syncytial virus--how soon will we have a vaccine?

G L Toms1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7717728      PMCID： PMC1510974          DOI： 10.1136/adc.72.1.1

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  19 in total

1.  Antigenic analysis of a putative new strain of respiratory syncytial virus.

Authors:  G A Prince; R L Horswood; D W Koenig; R M Chanock
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

2.  Further investigations of live respiratory syncytial virus vaccine administered parenterally.

Authors:  E B Buynak; R E Weibel; A J Carlson; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

3.  Repeated infections with respiratory syncytial virus.

Authors:  M Beem
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

4.  Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus.

Authors:  R M Hendry; J C Burns; E E Walsh; B S Graham; P F Wright; V G Hemming; W J Rodriguez; H W Kim; G A Prince; K McIntosh
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

Review 5.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 6.  An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines.

Authors:  B R Murphy; S L Hall; A B Kulkarni; J E Crowe; P L Collins; M Connors; R A Karron; R M Chanock
Journal:  Virus Res       Date:  1994-04       Impact factor: 3.303

7.  Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.

Authors:  M A Mufson; R B Belshe; C Orvell; E Norrby
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

8.  Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.

Authors:  P R Johnson; R A Olmsted; G A Prince; B R Murphy; D W Alling; E E Walsh; P L Collins
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

9.  Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.

Authors:  B R Murphy; E E Walsh
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

10.  Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.

Authors:  B R Murphy; G A Prince; E E Walsh; H W Kim; R H Parrott; V G Hemming; W J Rodriguez; R M Chanock
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.